Humanigen, Inc. (HGEN) Social Stream
HUMANIGEN INC (HGEN) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering HGEN.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-11 | 6 | $35 | $9 | $23 | $0.199 | 11457.79% |
| 2021-11-18 | 7 | $30 | $9 | $20.6 | $0.199 | 10251.76% |
| 2022-01-03 | 6 | $30 | $9 | $20.6 | $0.199 | 10251.76% |
| 2022-02-04 | 6 | $30 | $9 | $19.6 | $0.199 | 9749.25% |
| 2022-03-01 | 6 | $30 | $9 | $19.4 | $0.199 | 9648.74% |
| 2022-05-06 | 6 | $30 | $9 | $19.2 | $0.199 | 9548.24% |
| 2022-07-13 | 5 | $9 | $2 | $4.333 | $0.199 | 2077.39% |
| 2022-08-15 | 3 | $9 | $2 | $5.5 | $0.199 | 2663.82% |
| 2022-11-15 | 2 | $9 | $1 | $5 | $0.199 | 2412.56% |
| 2022-11-17 | 3 | $9 | $1 | $5 | $0.199 | 2412.56% |
| 2023-01-12 | 3 | $9 | $0.15 | $4.575 | $0.199 | 2198.99% |
| 2023-03-31 | 2 | $9 | $0.15 | $4.575 | $0.199 | 2198.99% |
| 2023-05-16 | 1 | $0.15 | $0.15 | $0.15 | $0.199 | -24.62% |
The Trend in the Analyst Price Target
HGEN's average price target has moved down $22.85 over the prior 19 months.
HGEN reports an average of 1,903.84% for its upside potential over the past 39 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-11-15 | 2 | 9 | 1.00 | 5.000 | 0.169 | 2858.58% |
| 2023-01-12 | 3 | 9 | 0.15 | 4.575 | 0.165 | 2672.73% |
| 2023-01-12 | 2 | 9 | 0.15 | 3.383 | 0.165 | 1950.3% |
| 2023-03-31 | 2 | 9 | 0.15 | 4.575 | 0.143 | 3099.3% |
| 2023-03-31 | 1 | 9 | 0.15 | 4.575 | 0.143 | 3099.3% |
HGEN Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 3 | 0 | 0 | 1 | 0 | 0 | 1 |
The Trend in the Broker Recommendations
Over the past 13 months, HGEN's average broker recommendation rating worsened by 1.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for HGEN as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, HUMANIGEN INC's upside potential (average analyst target price relative to current price) is higher than 1695.3% of them.
- HGEN has a lower variance in analysts' estimates than -1482.67% of all US stocks.
- In terms of how HUMANIGEN INC fares relative to Healthcare stocks, note that its average analyst price target is higher than 349.84% of that group.
- HUMANIGEN INC's number of analysts covering the stock is greater than 829.8% of stocks in the small market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to HUMANIGEN INC are MNOV, SVRA, and BPTH.
View All Top Stocks by Price Target
Make investment decisions regarding HGEN using the data that counts. Try POWR Ratings for free.